Thursday, January 31, 2013

IRR v/s Social Impact: Do financial institutions necessarily go through this dilemma?

›
The news on Times of India Social Impact Awards & what Nicolas Aguzin, chairman and CEO of JP Morgan- Asia-Pacific said during his s...
Monday, January 28, 2013

Drug discovery unable to attract big money! - Is innovation, rather the lack of it to blame?

›
Some interesting observations on early-stage funding for healthcare from the 2012 Venture Capital Activity Report published by  CB Insight...
Sunday, January 27, 2013

Generic Drug User Fee Act (GDUFA) - What will be the implications for the consumer & for the generic API manufacturers based outside NA & EU

›
20 August, 2011 Posted in Linkedin Answers by Murali Apparaju For those who remember SOCMA & EFCG making a fervent pitch in 2...
Saturday, January 26, 2013

NRAchists in gun-afflicted america....

›
December 2012 My comment on a LinkedIn article on need for Gun Control in USA, I only see the comments now, no article!!, still an int...
1 comment:

Caste, gender & slur - Quite an explosive cocktail!! :-)

›
01 March 2009 Wow, this repro' is a dinosaur, way back from 2009!!! - my comment below was on a real flamer of a topic that was origi...
Friday, January 25, 2013

3200% premium for innovation!!

›
April 2012 Discussion posted on Pharmaceutical Discussion Group on Linkedin http://www.linkedin.com/groups/PhRMA-says-price-as-trig...

Why won't Gates spend a few more cents (per dose) on non-mercury biocides & shut-up the vaccine detractors?

›
April 2012 Discussion posted on Pharmaceutical Discussion Group on LI - by Murali Apparaju http://www.linkedin.com/groups/Why-wont-G...
1 comment: